Literature DB >> 12461750

Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes.

Alicja M Gruszka-Westwood1, Rifat Hamoudi, Lucy Osborne, Estella Matutes, Daniel Catovsky.   

Abstract

Splenic lymphoma with villous lymphocytes (SLVL) is a low-grade lymphoproliferative disorder characterized by splenomegaly and circulating villous lymphocytes in the peripheral blood. It is considered to be the leukemic form of splenic marginal zone lymphoma (SMZL). The genetic basis of this lymphoma type remains unknown. Conventional cytogenetic studies have identified frequent structural abnormalities of chromosome 7, in the form of translocations, mainly unbalanced, and 7q deletions. In this current study, we undertook deletion mapping of the long arm of chromosome 7 in a series of cases with SLVL. Metaphase fluorescence in situ hybridization (FISH) was used in the first instance, followed by a study of loss of heterozygosity (LOH). The common area of deletion identified by FISH spanned from the YAC clone HSC7E1289 (mapping to 7q32.1) to in between YACs HSC7E195 and HSC7E648 (7q32-3). By application of 50 microsatellite markers mapping to the FISH-CDR and to areas of deletion reported in other studies, four distinct hotspot loci were identified, with abnormalities present in 29-55% cases. In three of them, both LOH and biallelic deletions were found. The LOH in the majority of patients was noncontiguous. The presence of a high incidence of abnormalities in the established hotspot areas and in particular the finding of biallelic deletions is indicative of the existence of genes important for the pathogenesis of SLVL in these areas. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12461750     DOI: 10.1002/gcc.10142

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.

Authors:  Piers A Blombery; Stephen Q Wong; Chelsee A Hewitt; Alexander Dobrovic; Ellen L Maxwell; Surender Juneja; George Grigoriadis; David A Westerman
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

2.  Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.

Authors:  Gunhild Trøen; Vigdis Nygaard; Tor-Kristian Jenssen; Ida Münster Ikonomou; Anne Tierens; Estella Matutes; Alicja Gruszka-Westwood; Daniel Catovsky; Ola Myklebost; Grete Lauritzsen; Eivind Hovig; Jan Delabie
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

3.  KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.

Authors:  A Clipson; M Wang; L de Leval; M Ashton-Key; A Wotherspoon; G Vassiliou; N Bolli; C Grove; S Moody; L Escudero-Ibarz; G Gundem; K Brugger; X Xue; E Mi; A Bench; M Scott; H Liu; G Follows; E F Robles; J A Martinez-Climent; D Oscier; A J Watkins; M-Q Du
Journal:  Leukemia       Date:  2014-11-27       Impact factor: 11.528

4.  Gliomas display a microRNA expression profile reminiscent of neural precursor cells.

Authors:  Iris Lavon; Daniel Zrihan; Avital Granit; Ofira Einstein; Nina Fainstein; Malkiel A Cohen; Mikhal A Cohen; Bracha Zelikovitch; Yigal Shoshan; Sergei Spektor; Benjamin E Reubinoff; Yakov Felig; Offer Gerlitz; Tamir Ben-Hur; Yohav Smith; Tali Siegal
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300

Review 5.  Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.

Authors:  Xavier Troussard; Edouard Cornet
Journal:  Curr Treat Options Oncol       Date:  2007-04

6.  An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.

Authors:  A James Watkins; Rifat A Hamoudi; Naiyan Zeng; Qingguo Yan; Yuanxue Huang; Hongxiang Liu; Jianzhong Zhang; Esteban Braggio; Rafael Fonseca; Laurence de Leval; Peter G Isaacson; Andrew Wotherspoon; Ellen D McPhail; Ahmet Dogan; Ming-Qing Du
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

7.  Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.

Authors:  Mark J Kiel; Thirunavukkarasu Velusamy; Bryan L Betz; Lili Zhao; Helmut G Weigelin; Mark Y Chiang; David R Huebner-Chan; Nathanael G Bailey; David T Yang; Govind Bhagat; Roberto N Miranda; David W Bahler; L Jeffrey Medeiros; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Exp Med       Date:  2012-08-13       Impact factor: 14.307

8.  Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells.

Authors:  Paraic A Kenny; Tariq Enver; Alan Ashworth
Journal:  BMC Cancer       Date:  2005-01-10       Impact factor: 4.430

Review 9.  Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA.

Authors:  Jacob E Robinson; Christine E Cutucache
Journal:  Oncotarget       Date:  2018-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.